Eric Ng writing for South China Morning Post reports that Guangzhou, in the southern part of China, has entered an outright race to build a biotech cluster. Competing against Shanghai and Suzhou as a center for the development of novel drugs, the southern Chinese city is extending incentives to win over major international players such as GE Healthcare.
